Copyright Reports & Markets. All rights reserved.

Global AI Disease Prediction Software Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of AI Disease Prediction Software by Type
    • 1.3.1 Overview: Global AI Disease Prediction Software Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global AI Disease Prediction Software Consumption Value Market Share by Type in 2024
    • 1.3.3 Cloud-based
    • 1.3.4 On-premises
  • 1.4 Global AI Disease Prediction Software Market by Application
    • 1.4.1 Overview: Global AI Disease Prediction Software Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Cancer
    • 1.4.3 Cardiovascular Disease
    • 1.4.4 Nervous System Disease
    • 1.4.5 Chronic Disease and Metabolic Disease
    • 1.4.6 Others
  • 1.5 Global AI Disease Prediction Software Market Size & Forecast
  • 1.6 Global AI Disease Prediction Software Market Size and Forecast by Region
    • 1.6.1 Global AI Disease Prediction Software Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global AI Disease Prediction Software Market Size by Region, (2020-2031)
    • 1.6.3 North America AI Disease Prediction Software Market Size and Prospect (2020-2031)
    • 1.6.4 Europe AI Disease Prediction Software Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific AI Disease Prediction Software Market Size and Prospect (2020-2031)
    • 1.6.6 South America AI Disease Prediction Software Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa AI Disease Prediction Software Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 IntelliGenes
    • 2.1.1 IntelliGenes Details
    • 2.1.2 IntelliGenes Major Business
    • 2.1.3 IntelliGenes AI Disease Prediction Software Product and Solutions
    • 2.1.4 IntelliGenes AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 IntelliGenes Recent Developments and Future Plans
  • 2.2 IBM Watson Oncology
    • 2.2.1 IBM Watson Oncology Details
    • 2.2.2 IBM Watson Oncology Major Business
    • 2.2.3 IBM Watson Oncology AI Disease Prediction Software Product and Solutions
    • 2.2.4 IBM Watson Oncology AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 IBM Watson Oncology Recent Developments and Future Plans
  • 2.3 PathAI
    • 2.3.1 PathAI Details
    • 2.3.2 PathAI Major Business
    • 2.3.3 PathAI AI Disease Prediction Software Product and Solutions
    • 2.3.4 PathAI AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 PathAI Recent Developments and Future Plans
  • 2.4 Zebra Medical Vision
    • 2.4.1 Zebra Medical Vision Details
    • 2.4.2 Zebra Medical Vision Major Business
    • 2.4.3 Zebra Medical Vision AI Disease Prediction Software Product and Solutions
    • 2.4.4 Zebra Medical Vision AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Zebra Medical Vision Recent Developments and Future Plans
  • 2.5 Siemens Healthineers
    • 2.5.1 Siemens Healthineers Details
    • 2.5.2 Siemens Healthineers Major Business
    • 2.5.3 Siemens Healthineers AI Disease Prediction Software Product and Solutions
    • 2.5.4 Siemens Healthineers AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Siemens Healthineers Recent Developments and Future Plans
  • 2.6 GitHub LifeAI
    • 2.6.1 GitHub LifeAI Details
    • 2.6.2 GitHub LifeAI Major Business
    • 2.6.3 GitHub LifeAI AI Disease Prediction Software Product and Solutions
    • 2.6.4 GitHub LifeAI AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 GitHub LifeAI Recent Developments and Future Plans
  • 2.7 DeepView
    • 2.7.1 DeepView Details
    • 2.7.2 DeepView Major Business
    • 2.7.3 DeepView AI Disease Prediction Software Product and Solutions
    • 2.7.4 DeepView AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 DeepView Recent Developments and Future Plans
  • 2.8 Google DeepMind
    • 2.8.1 Google DeepMind Details
    • 2.8.2 Google DeepMind Major Business
    • 2.8.3 Google DeepMind AI Disease Prediction Software Product and Solutions
    • 2.8.4 Google DeepMind AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Google DeepMind Recent Developments and Future Plans
  • 2.9 Binariks
    • 2.9.1 Binariks Details
    • 2.9.2 Binariks Major Business
    • 2.9.3 Binariks AI Disease Prediction Software Product and Solutions
    • 2.9.4 Binariks AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Binariks Recent Developments and Future Plans
  • 2.10 Paige.AI
    • 2.10.1 Paige.AI Details
    • 2.10.2 Paige.AI Major Business
    • 2.10.3 Paige.AI AI Disease Prediction Software Product and Solutions
    • 2.10.4 Paige.AI AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Paige.AI Recent Developments and Future Plans
  • 2.11 Lunit INSIGHT
    • 2.11.1 Lunit INSIGHT Details
    • 2.11.2 Lunit INSIGHT Major Business
    • 2.11.3 Lunit INSIGHT AI Disease Prediction Software Product and Solutions
    • 2.11.4 Lunit INSIGHT AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Lunit INSIGHT Recent Developments and Future Plans
  • 2.12 Arterys
    • 2.12.1 Arterys Details
    • 2.12.2 Arterys Major Business
    • 2.12.3 Arterys AI Disease Prediction Software Product and Solutions
    • 2.12.4 Arterys AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Arterys Recent Developments and Future Plans
  • 2.13 Winterlight Labs
    • 2.13.1 Winterlight Labs Details
    • 2.13.2 Winterlight Labs Major Business
    • 2.13.3 Winterlight Labs AI Disease Prediction Software Product and Solutions
    • 2.13.4 Winterlight Labs AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Winterlight Labs Recent Developments and Future Plans
  • 2.14 BrainScope
    • 2.14.1 BrainScope Details
    • 2.14.2 BrainScope Major Business
    • 2.14.3 BrainScope AI Disease Prediction Software Product and Solutions
    • 2.14.4 BrainScope AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 BrainScope Recent Developments and Future Plans
  • 2.15 Livongo
    • 2.15.1 Livongo Details
    • 2.15.2 Livongo Major Business
    • 2.15.3 Livongo AI Disease Prediction Software Product and Solutions
    • 2.15.4 Livongo AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Livongo Recent Developments and Future Plans
  • 2.16 Deep Genomics
    • 2.16.1 Deep Genomics Details
    • 2.16.2 Deep Genomics Major Business
    • 2.16.3 Deep Genomics AI Disease Prediction Software Product and Solutions
    • 2.16.4 Deep Genomics AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Deep Genomics Recent Developments and Future Plans
  • 2.17 IDx-DR
    • 2.17.1 IDx-DR Details
    • 2.17.2 IDx-DR Major Business
    • 2.17.3 IDx-DR AI Disease Prediction Software Product and Solutions
    • 2.17.4 IDx-DR AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 IDx-DR Recent Developments and Future Plans
  • 2.18 ChestEye
    • 2.18.1 ChestEye Details
    • 2.18.2 ChestEye Major Business
    • 2.18.3 ChestEye AI Disease Prediction Software Product and Solutions
    • 2.18.4 ChestEye AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 ChestEye Recent Developments and Future Plans
  • 2.19 Viz.ai
    • 2.19.1 Viz.ai Details
    • 2.19.2 Viz.ai Major Business
    • 2.19.3 Viz.ai AI Disease Prediction Software Product and Solutions
    • 2.19.4 Viz.ai AI Disease Prediction Software Revenue, Gross Margin and Market Share (2020-2025)
    • 2.19.5 Viz.ai Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global AI Disease Prediction Software Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of AI Disease Prediction Software by Company Revenue
    • 3.2.2 Top 3 AI Disease Prediction Software Players Market Share in 2024
    • 3.2.3 Top 6 AI Disease Prediction Software Players Market Share in 2024
  • 3.3 AI Disease Prediction Software Market: Overall Company Footprint Analysis
    • 3.3.1 AI Disease Prediction Software Market: Region Footprint
    • 3.3.2 AI Disease Prediction Software Market: Company Product Type Footprint
    • 3.3.3 AI Disease Prediction Software Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global AI Disease Prediction Software Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global AI Disease Prediction Software Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global AI Disease Prediction Software Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global AI Disease Prediction Software Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America AI Disease Prediction Software Consumption Value by Type (2020-2031)
  • 6.2 North America AI Disease Prediction Software Market Size by Application (2020-2031)
  • 6.3 North America AI Disease Prediction Software Market Size by Country
    • 6.3.1 North America AI Disease Prediction Software Consumption Value by Country (2020-2031)
    • 6.3.2 United States AI Disease Prediction Software Market Size and Forecast (2020-2031)
    • 6.3.3 Canada AI Disease Prediction Software Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico AI Disease Prediction Software Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe AI Disease Prediction Software Consumption Value by Type (2020-2031)
  • 7.2 Europe AI Disease Prediction Software Consumption Value by Application (2020-2031)
  • 7.3 Europe AI Disease Prediction Software Market Size by Country
    • 7.3.1 Europe AI Disease Prediction Software Consumption Value by Country (2020-2031)
    • 7.3.2 Germany AI Disease Prediction Software Market Size and Forecast (2020-2031)
    • 7.3.3 France AI Disease Prediction Software Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom AI Disease Prediction Software Market Size and Forecast (2020-2031)
    • 7.3.5 Russia AI Disease Prediction Software Market Size and Forecast (2020-2031)
    • 7.3.6 Italy AI Disease Prediction Software Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific AI Disease Prediction Software Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific AI Disease Prediction Software Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific AI Disease Prediction Software Market Size by Region
    • 8.3.1 Asia-Pacific AI Disease Prediction Software Consumption Value by Region (2020-2031)
    • 8.3.2 China AI Disease Prediction Software Market Size and Forecast (2020-2031)
    • 8.3.3 Japan AI Disease Prediction Software Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea AI Disease Prediction Software Market Size and Forecast (2020-2031)
    • 8.3.5 India AI Disease Prediction Software Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia AI Disease Prediction Software Market Size and Forecast (2020-2031)
    • 8.3.7 Australia AI Disease Prediction Software Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America AI Disease Prediction Software Consumption Value by Type (2020-2031)
  • 9.2 South America AI Disease Prediction Software Consumption Value by Application (2020-2031)
  • 9.3 South America AI Disease Prediction Software Market Size by Country
    • 9.3.1 South America AI Disease Prediction Software Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil AI Disease Prediction Software Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina AI Disease Prediction Software Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa AI Disease Prediction Software Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa AI Disease Prediction Software Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa AI Disease Prediction Software Market Size by Country
    • 10.3.1 Middle East & Africa AI Disease Prediction Software Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey AI Disease Prediction Software Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia AI Disease Prediction Software Market Size and Forecast (2020-2031)
    • 10.3.4 UAE AI Disease Prediction Software Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 AI Disease Prediction Software Market Drivers
  • 11.2 AI Disease Prediction Software Market Restraints
  • 11.3 AI Disease Prediction Software Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 AI Disease Prediction Software Industry Chain
  • 12.2 AI Disease Prediction Software Upstream Analysis
  • 12.3 AI Disease Prediction Software Midstream Analysis
  • 12.4 AI Disease Prediction Software Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our latest research, the global AI Disease Prediction Software market size will reach USD 4896 million in 2031, growing at a CAGR of 11.4% over the analysis period.
    AI disease prediction software is a tool developed using artificial intelligence technologies (such as machine learning, deep learning, big data analysis, etc.), which aims to predict disease risks, early diagnosis or prognosis assessment by analyzing patient data (such as medical records, images, genetic information, etc.).

    This report is a detailed and comprehensive analysis for global AI Disease Prediction Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global AI Disease Prediction Software market size and forecasts, in consumption value ($ Million), 2020-2031
    Global AI Disease Prediction Software market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global AI Disease Prediction Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global AI Disease Prediction Software market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for AI Disease Prediction Software
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global AI Disease Prediction Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IntelliGenes, IBM Watson Oncology, PathAI, Zebra Medical Vision, Siemens Healthineers, GitHub LifeAI, DeepView, Google DeepMind, Binariks, Paige.AI, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    AI Disease Prediction Software market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Cloud-based
    On-premises
    Market segment by Application
    Cancer
    Cardiovascular Disease
    Nervous System Disease
    Chronic Disease and Metabolic Disease
    Others
    Market segment by players, this report covers
    IntelliGenes
    IBM Watson Oncology
    PathAI
    Zebra Medical Vision
    Siemens Healthineers
    GitHub LifeAI
    DeepView
    Google DeepMind
    Binariks
    Paige.AI
    Lunit INSIGHT
    Arterys
    Winterlight Labs
    BrainScope
    Livongo
    Deep Genomics
    IDx-DR
    ChestEye
    Viz.ai
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe AI Disease Prediction Software product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of AI Disease Prediction Software, with revenue, gross margin, and global market share of AI Disease Prediction Software from 2020 to 2025.
    Chapter 3, the AI Disease Prediction Software competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and AI Disease Prediction Software market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of AI Disease Prediction Software.
    Chapter 13, to describe AI Disease Prediction Software research findings and conclusion.

    Buy now